La Jolla Pharmaceutical Chief Commercial Officer Darryl Wellinghoff receives $967K in 2019
La Jolla Pharmaceutical reports 2019 executive compensation
By ExecPay News
Published: April 29, 2020
La Jolla Pharmaceutical reported fiscal year 2019 executive compensation information on April 29, 2020.
In 2019, five executives at La Jolla Pharmaceutical received on average a compensation package of $722K, a 24% decrease compared to previous year.
Average pay of disclosed executives at La Jolla Pharmaceutical
Darryl Wellinghoff, Chief Commercial Officer, received $967K in total. 60% of Wellinghoff's compensation, or $578K, was in option awards. Wellinghoff also received $63K in non-equity incentive plan, $315K in salary, as well as $9.7K in other compensation.
Jennifer A. Carver, Chief Operating Officer, received a compensation package of $774K, which decreased by 2% compared to previous year. 50% of the compensation package, or $388K, was in other compensation.
Lakhmir S. Chawla, Chief Medical Officer, earned $691K in 2019, a 12% decrease compared to previous year.
Dennis M. Mulroy, Chief Financial Officer, received $613K in 2019, which decreases by 14% compared to 2018.
George F. Tidmarsh, Chief Executive Officer, earned $568K in 2019, a 62% decrease compared to previous year.
Related executives
Dennis Mulroy
La Jolla Pharmaceutical
Chief Financial Officer
Lakhmir Chawla
La Jolla Pharmaceutical
Chief Medical Officer
Darryl Wellinghoff
La Jolla Pharmaceutical
Chief Commercial Officer
George Tidmarsh
La Jolla Pharmaceutical
Chief Executive Officer
Jennifer Carver
La Jolla Pharmaceutical
Chief Operating Officer
You may also like
Source: SEC filing on April 29, 2020.